Full text is available at the source.
Abstract
A relationship between metformin and COVID-19 sequelae was evaluated.
- Metformin is widely prescribed for diabetes management.
- COVID-19 sequelae refer to the long-term effects experienced after infection.
- The evaluation aimed to assess if metformin use is associated with these post-COVID-19 outcomes.
- Findings may provide insights into the role of diabetes medication during viral infections.
Simplified